Moreover, RIPK1 involvement has been suggested in the pathogenesis of NAFLD, as Majdi et al. found an increased level of RIPK1 in the serum samples of NAFLD patients [101]. Here, RIPK1 is linked to metabolic dysfunction-associated steatotic liver disease.